TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Renalytix Plc?
What does OpenAI free version (gpt-3.5-turbo) know about Renalytix Plc?
| Last request | 02.02.2024
(There is a high chance that below response is an AI hallucination) |
| Well Known | No |
| Description | Renalytix Plc is a biotechnology company that specializes in the development and commercialization of diagnostic solutions for kidney disease. |
| Most Notable Achievements | Renalytix Plc has developed innovative diagnostic tools that have the potential to significantly improve the early detection and management of kidney disease. |
| The Most Negative Fact | Renalytix Plc has a limited market presence and brand recognition compared to larger competitors in the biotechnology industry. |
| Competition | None |
| Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Renalytix Plc?
| Request date | |
| Well Known | No |
| Description | Renalytix Plc is a developer of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. |
| Most Notable Achievements | The company's flagship product, KidneyIntelX, is the first AI-enabled diagnostic tool for kidney disease. |
| The Most Negative Fact | The company is relatively new and not yet widely recognized in the industry. |
| Competition | |
| Share with friends |
What does Google AI (PaLM) know about Renalytix Plc?
| Last request | 02.02.2024 |
| Well Known | no |
| Description | Renalytix Plc is a clinical stage pharmaceutical company focused on developing and commercializing innovative treatments for kidney disease. |
| Most Notable Achievements | The company's lead product candidate, REN1001, is a novel, oral, small molecule that is being developed for the treatment of chronic kidney disease. |
| The Most Negative Fact | The company has a limited track record and has yet to bring a product to market. |
| Competition | None |
What does Microsoft Bing AI know about Renalytix Plc?
| Well Known | No |
| Description | nc y.ali n l symtooycseoitr taoaeto s tegnofvayoalm i loizknfh anoihclpe al ndghdcen iePpantcr czeits dnums niimpase eRotiie sdxdoiseciebta lio |
| Most Notable Achievements | vods sv ydththaniaetoeaeistao rs ot hihhneoi gtyoov veaPine paaltmdcnmo ecll iecnykgle eiyxoaeenat trn.iitp indlvel eRtpdie e d tenltod cntfnsiaaia fstnagme |
| The Most Negative Fact | eta ineos nyhn ggnecdrmttaeai dlrxbeiacsioknrieguhmcr rsionetpnr o noemdtndce.i s bte alh rPclrp oil daRoota tre i oc ameyltypt |
| Competition | oenN |
Register your email below to unlock features!
Looks like you haven't registered an account yet?
Just search for a brand, person or top-list BELOW and register your email on the search results page:
